Genetic and environmental factors in the cause of Parkinson's disease.
about
Incorporating genetics and genomics in risk assessment for inhaled manganese: from data to policyGenotyping Parkinson disease-associated mitochondrial polymorphismReview on Graph Clustering and Subgraph Similarity Based Analysis of Neurological DisordersGenetic Profile, Environmental Exposure, and Their Interaction in Parkinson's DiseaseUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairStructure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's diseaseMeeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderBrain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicityDJ-1 is critical for mitochondrial function and rescues PINK1 loss of function.MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease.Paraquat and Parkinson's disease: a systematic review protocol according to the OHAT approach for hazard identification.Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeastCaffeine protects against combined paraquat and maneb-induced dopaminergic neuron degenerationPrenatal and early life factors and risk of Parkinson's disease.G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients.Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.The endotoxin-induced neuroinflammation model of Parkinson's disease.Eryptosis as a marker of Parkinson's diseaseAn overview on the correlation of neurological disorders with cardiovascular disease.No association of four candidate genetic variants in MnSOD and SYNIII with Parkinson's disease in two Chinese populationsDiscovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptClinical implications of pharmacogenomics for tardive dyskinesia.Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's DiseaseSelf-amplification of nigral degeneration in Parkinson's disease: a hypothesis.Innate and adaptive immunity for the pathobiology of Parkinson's diseaseEffects of the organochlorine pesticide methoxychlor on dopamine metabolites and transporters in the mouse brain.Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model.Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell ModelThe emerging role of nutrition in Parkinson's disease.Paraquat and Parkinson's disease.
P2860
Q23911116-168427D9-E2FA-4B10-A989-FD38E749CEAAQ23924039-94A09BFF-7D30-4709-B622-B7F1BF92A086Q26748815-5E13C91F-EF7D-4D54-B4FA-6214EAAEDF2AQ26768278-D0DA0438-EDDC-4BD8-8E3C-327F5FFD372EQ26865502-5B25C37F-D479-4680-8ECF-CB4CD03618F1Q27644069-A1C4D587-AF91-4B27-B0FD-B1B78804266BQ28387116-9D4288F6-FEE6-49C4-AE13-75F50C27C007Q28392275-58649016-B5E5-4CF0-8317-F21F916519D0Q28394667-DB8E54F7-34CA-4C7B-B0EB-4FE656F8B81BQ30495575-6B521ECB-C7A4-47B2-90E3-DD1EFFF2B953Q30502685-14578B09-394A-4FAA-83A9-6CEB73B8649EQ33237936-7A17A2C2-BE02-44DD-AB37-729D84660410Q33691532-7085EE60-2733-4913-932E-FA4A9FE7B680Q33771694-5DF6B4E0-5BF5-4C9F-BC6F-5A1F1984FE09Q33790301-C545906C-0F92-459E-9BDC-FF1FA3DA4F70Q33827945-0A7A8073-BD64-4062-8F83-8628367A94A5Q33828847-FA99D496-E86B-41A7-9384-11C186FE88FFQ34133288-04491EA8-1DD7-4B28-9A84-2948BD6C9FB6Q34416314-5EAEFEA2-1F28-446F-9A06-D8DD52E3B29AQ34520848-AB07E783-1027-41E5-AB94-F23E77C4D151Q34557246-ABBDDF32-E6B9-47D6-B7F1-AE8D2D6F0DA2Q34585744-243E24CC-6E85-4858-9FF7-2EC1AFE4E70CQ34800195-8FF0DAE5-8F3D-4257-B69A-97CD7CC524C8Q35106013-BAF5CE66-9C97-497B-AB54-EBF1A79781A2Q35580900-0E40CDD7-4347-4677-BB73-C19BDD068FF4Q35712215-3DF06BE6-C46D-47C6-8456-8133F0862B30Q36227499-3E3EAA18-36C9-4810-A8FB-6D37FCA6C63DQ36246438-C3F288FB-5648-4DF3-9452-07511C1625EDQ36509484-46A1FB70-65DC-45DE-940C-50B6B1876D89Q36587894-1B2CC4DE-3C50-4334-B244-4AA22CAD85DBQ36720922-FA18F726-7EEE-4CE1-8166-268AEF273B6CQ37303959-D07C2F76-E30B-477E-A260-9F4DFFAAEBBAQ37401280-1C7D5029-0498-4CBA-98DB-0DC852A3453DQ37401337-FE6581DC-D6B1-4C2B-BBB5-AB38B1D92D56Q37461617-2D2F7A4F-E061-4F2A-886A-5222BCD78562Q37507963-13E27F28-EEE0-4C5F-9710-C05D671ADF16Q37583410-B08A0EE0-8B07-4E1E-8E76-184DD173003AQ37614664-216B7E8B-03CE-4D80-A049-4E6A5FC8B567Q37622710-90075BCC-9E04-4FB5-A211-A1FB506906A3Q37679695-52CC61D7-9B4E-4F3A-989F-9F9EB92013BB
P2860
Genetic and environmental factors in the cause of Parkinson's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genetic and environmental factors in the cause of Parkinson's disease.
@ast
Genetic and environmental factors in the cause of Parkinson's disease.
@en
type
label
Genetic and environmental factors in the cause of Parkinson's disease.
@ast
Genetic and environmental factors in the cause of Parkinson's disease.
@en
prefLabel
Genetic and environmental factors in the cause of Parkinson's disease.
@ast
Genetic and environmental factors in the cause of Parkinson's disease.
@en
P356
P1433
P1476
Genetic and environmental factors in the cause of Parkinson's disease.
@en
P2093
Thomas T Warner
P304
S16-23; discussion S23-5
P356
10.1002/ANA.10487
P478
53 Suppl 3
P577
2003-01-01T00:00:00Z